Edition:
United States

Pharmswell Bio Co Ltd (043090.KQ)

043090.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

3,415.00KRW
30 Mar 2017
Change (% chg)

₩0.00 (+0.00%)
Prev Close
₩3,415.00
Open
₩3,470.00
Day's High
₩3,470.00
Day's Low
₩3,360.00
Volume
84,827
Avg. Vol
212,093
52-wk High
₩5,770.00
52-wk Low
₩2,995.00

Latest Key Developments (Source: Significant Developments)

Pharmswell Bio says subscription results of 11th series convertible bonds
Thursday, 23 Feb 2017 03:08am EST 

Pharmswell Bio Co Ltd <043090.KQ> : Says all of its 11th series unregistered and unsecured private convertible bonds have been subscribed on Feb. 22 .Says it has raised 1.50 billion won in total.  Full Article

PharmswellBio to issue 10th series convertible bonds worth 3 bln won
Wednesday, 8 Feb 2017 09:55pm EST 

Pharmswell Bio Co Ltd <043090.KQ> : Says it will issue 10th series unregistered and unsecured private convertible bonds to raise 3 billion won in proceeds for operations . Maturity date is March 15, 2020, coupon rate is 2 percent and yield to maturity is 4 percent for the bonds .Conversion price is 4,044 won/share and conversion ratio is 100 percent.  Full Article

Pharmswell Bio to dispose treasury shares for 2.60 bln won
Thursday, 26 Jan 2017 04:20am EST 

Pharmswell Bio Co Ltd <043090.KQ> : Says it will sell 745,990 shares of common stock from Jan. 27 to April 25 .Says offering price is 3,490 won/share, 2.60 billion won in total.  Full Article

Pharmswell Bio to raise 1 bln won via private offering
Friday, 14 Oct 2016 06:00am EDT 

Pharmswell Bio Co Ltd <043090.KQ> :Says it will raise 1 billion won in private offering of shares.  Full Article

Pharmswell Bio appoints Jang Yeong Jin as co-CEO
Thursday, 23 Jun 2016 02:50am EDT 

Pharmswell Bio Co., Ltd. <043090.KQ>: Says it changes co-CEO to Jang Yeong Jin from Lee Yeong Mi .Says Choo Yeon Wu still serves as co-CEO of the company as well.  Full Article

PharmswellBio converses convertible bonds worth 1.1 bln won
Monday, 20 Jun 2016 02:44am EDT 

PharmswellBio Co., Ltd. <043090.KQ>:Says 1.1 billion won worth of its sixth and seventh convertible bonds have been converted into 233,832 shares at 4,704 won and 4,705 won per share respectively.  Full Article

Pharmswell Bio says conversion of sixth convertible bonds worth 1.3 bln won
Friday, 13 May 2016 03:39am EDT 

PharmswellBio Co., Ltd. <043090.KQ> : Says 200 mln won worth of its sixth convertible bonds have been converted into 42,517 shares of the company at 4,704 won per share, as of April 22, with listing date of May 13 . Says 300 mln won worth of its sixth convertible bonds have been converted into 63,775 shares of the company at 4,704 won per share, as of May 12, with listing date of May 27 .Says 800 mln won worth of its sixth convertible bonds have been converted into 170,067 shares of the company at 4,704 won per share, as of May 13, with listing date of May 27.  Full Article

PharmswellBio cancels private placement of common shares
Friday, 19 Feb 2016 03:03am EST 

PharmswellBio Co., Ltd:Cancels private placement of 210,659 shares of common stock, which was initially announced on Nov. 24, 2015.The company aimed to raise proceeds of 999,998,273 won from the issuance.  Full Article

PharmswellBio completes issuance of ninth convertible bonds
Wednesday, 13 Jan 2016 01:59am EST 

PharmswellBio Co., Ltd:Completes the issuance of its ninth convertible bonds as of Jan. 13.Proceeds of 2,000 mln won from the offering.  Full Article

PharmswellBio to issue ninth convertible bonds
Wednesday, 13 Jan 2016 01:48am EST 

PharmswellBio Co., Ltd:To issue the ninth unregistered/unsecured private convertible bonds, raising 2,000 mln won in proceeds for operations.Says maturity date of Jan. 13, 2019, yield to maturity of 6.0 pct and annual coupon of 6.0 pct, lump-sum redemption of principal on maturity date for the bonds.Says a 100 pct conversion rate of bonds to common shares at 4,597 won per share, and a conversion period from Jan. 13, 2017 to Dec. 13, 2018.  Full Article

More From Around the Web

No consensus analysis data available.